BiotechTubeBiotechTube
Home/4D Molecular Therapeutics/Robert Kim
RK

Robert Kim

Chief Medical Officer

4D Molecular Therapeutics

Roles

Chief Medical Officerat4D Molecular Therapeutics
Vice President of ResearchatPolaryx Therapeutics
Chief Medical OfficeratCharacter Biosciences

Therapeutic Areas

OphthalmologyPulmonologyRare Disease

4D Molecular Therapeutics Pipeline

DrugIndicationPhase
4D-150Wet Age-Related Macular Degeneration (wet AMD)Phase 3
4D-710Cystic Fibrosis (CF) lung diseasePhase 1/2
4D-125X-Linked Retinitis Pigmentosa (XLRP)Phase 1/2

Leadership Team at 4D Molecular Therapeutics

DK
David Kirn
Co-Founder and Chief Executive Officer
CK
Christine Kay
MD, Principal Investigator (PRISM trial)
EA
Erik Allison
Communications/Medical Affairs (inferred from author credit)
DA
David Anderson
Communications/Medical Affairs (inferred from author credit)
M
Malina
Corporate Communications/Web Manager (inferred from author credit)
View full 4D Molecular Therapeutics profile